Literature DB >> 18622088

The influence of auxology and long-term glycemic control on muscle function in children and adolescents with type 1 diabetes mellitus.

O Fricke1, O Seewi, O Semler, B Tutlewski, A Stabrey, E Schoenau.   

Abstract

We intended to investigate in this pilot-study if long-term glycemic control stands in close relationship with muscle function in children and adolescents with type 1 diabetes mellitus (T1DM). Muscle function (MIGF, maximal isometric grip force; PJF, peak jump force; PJP, peak jump power) was investigated in 40 children and adolescents (males 20, females 20; age 13.5-/+2.5 yr) affected with T1DM. Muscular parameters were correlated with anthropometric parameters (age, height, weight) and with glycosylated hemoglobin (HbA1c) of the presence and the past. Standard deviation scores (SDSs) of weight and MIGF indicated significantly higher weight (mean 0.75-/+1.83 (SD)) and lower MIGF (mean -1.06-/+1.76 (SD)) in individuals with T1DM. When the study group was divided into two groups by the criteria that the actual HbA1c (HbA1c0) was lower (N=25) or higher (N=15) than 8.5%, the comparison showed significantly higher muscular parameters (PJF-SDS, PJP-SDS and MIGF-SDS) in individuals with higher HbA1c0. Multiple regression analyses demonstrated that body weight and height primarily predicted muscle force (MIGF, PJF) in T1DM. In conclusion, skeletal growth is an important determinant for the development of muscle function in children and adolescents with T1DM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18622088

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN: 1108-7161            Impact factor:   2.041


  4 in total

1.  Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

Authors:  Carly S Gordon; Antonio S Serino; Matthew P Krause; Jonathan E Campbell; Enzo Cafarelli; Olasunkanmi A J Adegoke; Thomas J Hawke; Michael C Riddell
Journal:  PLoS One       Date:  2010-11-17       Impact factor: 3.240

Review 2.  Skeletal muscle as a therapeutic target for delaying type 1 diabetic complications.

Authors:  Samantha K Coleman; Irena A Rebalka; Donna M D'Souza; Thomas J Hawke
Journal:  World J Diabetes       Date:  2015-12-10

3.  Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study.

Authors:  Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis
Journal:  Diabetologia       Date:  2021-05-04       Impact factor: 10.122

4.  Inhibition of plasminogen activator inhibitor-1 restores skeletal muscle regeneration in untreated type 1 diabetic mice.

Authors:  Matthew P Krause; Jasmin Moradi; Aliyah A Nissar; Michael C Riddell; Thomas J Hawke
Journal:  Diabetes       Date:  2011-05-18       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.